The human pigment epithelium derived factor kit, which mostly uses the ELISA principle, has high sensitivity, strong specificity, and good stability. It is suitable for scientific research and clinical practice, easy to operate, and provides strong support for disease research and diagnosis.
Human pigment epithelium derived factor kit
Human pigment epithelium derived factor kitIt is a biological detection tool used to detect the content of PEDF in human samples, which plays an important role in medical research and clinical diagnosis. Here is the relevant introduction:
The principle of enzyme-linked immunosorbent assay (ELISA) is usually used. The reagent kit contains specific antibodies against PEDF, which can bind specifically to PEDF in the sample. By adding an enzyme-linked immunosorbent assay (ELISA) secondary antibody, an antigen antibody ELISA secondary antibody complex is formed. Then, a substrate is added, and the enzyme catalyzes the color development of the substrate. By comparing the color intensity with the standard, the content of PEDF in the sample can be quantitatively analyzed.
high sensitivityIt can detect extremely low concentrations of PEDF, even if the PEDF content in the sample is small, it can be accurately detected with a minimum detection limit of up to picogram level, which helps to detect subtle changes in PEDF in early disease states.
Strong specificityBy using highly specific antibodies, PEDF can be accurately identified without cross reactivity with other related proteins or impurities, ensuring the accuracy of test results and reducing false positive and false negative results.
Good stabilityStrict production processes and quality control ensure that the reagent kit maintains stable performance within its shelf life under specified storage conditions, such as 2-8 ℃, and the test results between different batches have good consistency.
research fieldIt can be used to study the mechanism of PEDF in normal physiological processes, as well as its expression changes in pathological states such as eye diseases, tumors, and cardiovascular diseases, providing important basis for the study of disease pathogenesis.
Clinical diagnosis: Assist in the diagnosis of some diseases related to the abnormal expression of PEDF, such as age-related macular degeneration, diabetes retinopathy and other eye diseases. The detection of PEDF levels in patients' serum, aqueous humor, vitreous body and other samples is conducive to the early diagnosis, disease assessment and treatment monitoring of diseases.
The reagent kit is equipped with detailed operating instructions, which generally include steps such as sample collection and processing, sample addition, incubation, washing, addition of enzyme-linked immunosorbent assay secondary antibody, incubation, washing, substrate color development, reaction termination, and result reading. The operation is relatively simple and can be accurately operated by trained professionals, but it is necessary to strictly follow the instructions to ensure the reliability of the test results.
